| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.067 | 0.2 |